🇺🇸 FDA
Patent

US 8591922

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

granted A61KA61K31/19A61K31/554

Quick answer

US patent 8591922 (Gamma-hydroxybutyrate compositions and their use for the treatment of disorders) held by Jazz Pharmaceuticals, Inc. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals, Inc.
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/19, A61K31/554, A61K9/0053, A61K9/08